*  Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
... Alessandro Conti,1 Matteo Santoni,2 Consuelo ... Therefore, in this review we illustrate the progress of molecular targeted therapy, describing the emerging agents in course of ... targeted therapies. The increasing awareness of the molecular mechanisms underlying tumor angiogenesis in RCC parallels the ... enrolling 550 patients who must have received one VEGF-targeted therapy and one prior mTOR inhibitor therapy to evaluate ...
  https://www.hindawi.com/journals/bmri/2013/419176/
*  Cancer Signaling : From Molecular Biology to Targeted Therapy (Paperback) (Christoph Wagener & Carol : Target
From Molecular Biology to Targeted Therapy (Paperback) (Christoph Wagener & Carol online on Target.com. ... Cancer Signaling : From Molecular Biology to Targeted Therapy (Paperback) (Christoph Wagener & Carol. ... and how targeted therapies using kinase inhibitors and other modulators of signaling pathways can contain and eventually cure ... Target/Movies, Music & Books/Books/See More Genres/Science & Nature‎. product description page. ...
  https://www.target.com/p/cancer-signaling-from-molecular-biology-to-targeted-therapy-paperback-christoph-wagener-carol/-/A-52115279
*  Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma - Full Text View - ClinicalTrials.gov
Matched targeted therapy Patients with BRAF and NRAS wild type tumour for whom there is a targeted therapy available, will ... Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma (MatchMel). The safety and scientific ... Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma. Estimated Study Start Date :. February ... Drug: Standard therapy or clinical trial Drug: Matched targeted therapy Drug: Trametinib and / or supportive care Phase 4 ...
  https://www.clinicaltrials.gov/ct2/show/NCT02645149?term=melanoma&rank=4
*  Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention | OMICS International
Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention Nagi Kumar1,2* and Ganna Chornokur1 ... Citation: Nagi Kumar, Chornokur G (2012) Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention. ... Our data strongly suggest that the proteasome is a PCa-related molecular target of EGCG and Polyphenon E, and that inhibition ... Adhami VM, Ahmad N, Mukhtar H (2003) Molecular targets for green tea in prostate cancer prevention. J Nutr 133: 2417S-2424S. ...
  https://www.omicsonline.org/molecular-targeted-therapies-using-botanicals-for-prostate-cancer-chemoprevention-2161-1025.S2-005.php?aid=12448
*  SapC-DOPS Nanovesicles as Targeted Therapy for Lung Cancer | Molecular Cancer Therapeutics
SapC-DOPS Nanovesicles as Targeted Therapy for Lung Cancer. Shuli Zhao, Zhengtao Chu, Victor M. Blanco, Yunzhong Nie, Yayi Hou ... SapC-DOPS Nanovesicles as Targeted Therapy for Lung Cancer. Shuli Zhao, Zhengtao Chu, Victor M. Blanco, Yunzhong Nie, Yayi Hou ... SapC-DOPS Nanovesicles as Targeted Therapy for Lung Cancer. Shuli Zhao, Zhengtao Chu, Victor M. Blanco, Yunzhong Nie, Yayi Hou ... Phosphatidylserine-targeted molecular imaging of tumor vasculature by magnetic resonance imaging. J Biomed Nanotechnol 2014;10: ...
  http://mct.aacrjournals.org/content/14/2/491
*  Molecular Profiling-Based Targeted Therapy in Treating Patients With Advanced Solid Tumors - Full Text View - ClinicalTrials.gov
Molecular Profiling-Based Targeted Therapy in Treating Patients With Advanced Solid Tumors. The safety and scientific validity ... This randomized pilot phase II trial studies molecular profiling-based targeted therapy in treating patients with solid tumors ... Molecular Profiling-Based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors. ... TREATMENT: Any prior therapy, radiotherapy, or major surgery must have been completed ,= 3 weeks (, 6 weeks for nitrosoureas or ...
  https://clinicaltrials.gov/ct2/show/NCT01827384?term=MPACT&rank=3
*  Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma - Full Text View - ClinicalTrials...
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma (RIST-rNB-2011). The safety and ... molecular targeted therapy. protein kinase inhibitor. mTOR Inhibitor. cytostatic topoisomerase-I-inhibitor. temozolomide. ... Prospective, Open Label, Randomized Phase II Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent ... The intention is to assess the therapeutic benefit of molecular targeted drugs for the treatment of rNB. ...
  https://clinicaltrials.gov/ct2/show/NCT01467986
*  Cancer Signaling: From Molecular Biology To Targeted Therapy | Christoph Wagener | 9783527336586 | Wiley
From Molecular Biology To Targeted Therapy al precio 5385,00 € de Christoph Wagener , Carol Stocking , Oliver Muller, tienda de ... Cancer Signaling: From Molecular Biology To Targeted Therapy (Christoph Wagener; Carol Stocking; Oliver Muller). · Manejo Terap ... and how targeted therapies using kinase inhibitors and other modulators of signaling pathways can contain and eventually cure ... Molecular action of TP53 in carcinogenesis. The Wnt pathway in a normal and in a tumor cell. Effects of proteinases with ...
  http://www.libreriasaulamedica.com/Cancer-Signaling-From-Molecular-Biology-To-Targeted-Therapy_9783527336586_275513
*  Nanoparticle Albumin-Bound-Paclitaxel in the Treatment of Metastatic Urethral Adenocarcinoma: The Significance of Molecular...
The Significance of Molecular Profiling and Targeted Therapy," Case Reports in Urology, vol. 2014, Article ID 489686, 3 pages, ... The Significance of Molecular Profiling and Targeted Therapy. Yasmin M. Abaza1 and Carlos Alemany2 ...
  https://www.hindawi.com/journals/criu/2014/489686/cta/
*  Basal Cell Carcinoma: From the Molecular Understanding of the Pathogenesis to Targeted Therapy of Progressive Disease
... novel therapies, as well as drug sensitivity and resistance. ... Molecular Understanding of the Pathogenesis to Targeted Therapy ... While one single microRNA regulates hundreds of target genes, the task is to focus its efficacy on the essential target and ... and its clinical aspects that would simplify the indication for a targeted therapy. Of equal importance in this complex ... of the molecular pathogenesis of BCC and its causative aberrant pathway has rendered a new therapeutic targeted approach ...
  https://www.hindawi.com/journals/jsc/2011/650258/
*  Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and...
All Hepatocellular carcinoma and Renal cell carcinoma patients who receive molecular targeted therapy will be candidates for ... To define genotypes of HCC and RCC patients who will likely to response to molecular targeted therapy. ... All Hepatocellular carcinoma and Renal cell carcinoma patients who receive molecular targeted therapy will be candidates for ... All Hepatocellular carcinoma and Renal cell carcinoma patients who receive molecular targeted therapy will be candidates for ...
  https://clinicaltrials.gov/ct2/show/NCT01482520?recr=Open&cond=%22Carcinoma%22&rank=12
*  IJMS | Free Full-Text | Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and...
... directed therapy in breast cancer, and CD20-targeted therapy in B cell lymphoma). Moreover, there are results indicating that ... Recently, molecular targeted agents have been applied in the clinic and have shown groundbreaking results in specific patient ... In this article, we review molecular targeted agents for managing LMC. ... targeted therapy or an anaplastic lymphoma kinase (ALK) inhibitor in lung cancer, human epidermal growth factor receptor 2 ( ...
  http://www.mdpi.com/1422-0067/17/7/1074
*  Abstract C120: Genomic landscape in advanced metaplastic breast cancer and outcomes with mTOR targeted therapy. | Molecular...
Abstract C120: Genomic landscape in advanced metaplastic breast cancer and outcomes with mTOR targeted therapy.. Filip Janku, ... Genomic landscape in advanced metaplastic breast cancer and outcomes with mTOR targeted therapy. [abstract]. In: Proceedings of ... Abstract C120: Genomic landscape in advanced metaplastic breast cancer and outcomes with mTOR targeted therapy. ... Abstract C120: Genomic landscape in advanced metaplastic breast cancer and outcomes with mTOR targeted therapy. ...
  http://mct.aacrjournals.org/content/12/11_Supplement/C120
*  Focal segmental glomerulosclerosis: molecular genetics and targeted therapies | BMC Nephrology | Full Text
A stratified and targeted approach based on the underlying molecular defects is evolving. ... Alternative & Novel therapies for FSGS. Table 2 lists novel therapies based on different disease mechanisms and most of them ... A stratified and targeted approach based on the underlying molecular defects is evolving. ... and investigating their underlying molecular mechanisms have immense potential for the development of highly-targeted therapy. ...
  https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-015-0090-9
*  Effect of molecular-targeted therapy on the progress and survival of people in the late stages of stomach cancer | Cochrane
Effect of molecular-targeted therapy on the progress and survival of people in the late stages of stomach cancer. Review ... We found low-quality evidence that molecular-targeted therapy may increase tumor response (OR 1.24, 95% CI 1.00 to 1.55, low- ... Does molecular-targeted therapy (a type of treatment specifically targeting cancer cells) benefit people with late-stage ... To evaluate the efficacy and safety of molecular-targeted therapy , either alone or in combination with chemotherapy, in people ...
  http://www.cochrane.org/CD011461/UPPERGI_effect-molecular-targeted-therapy-progress-and-survival-people-late-stages-stomach-cancer
*  SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer...
... clinicaltrials.gov The study will evaluate the efficacy of targeted therapy based on tumor molecular profiling versus ... Home » Topics » Cancer » Research » SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling ... SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer ... More From BioPortfolio on "SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in ...
  https://www.bioportfolio.com/resources/trial/177282/SHIVA02-Evaluation-of-the-Efficacy-of-Targeted-Therapy-Based-on-Tumor-Molecular.html
*  Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit...
In patients receiving targeted therapy, melanomas resistant to targeted therapy were enriched in the MITF-low proliferative ... Prediction of survival outcome and benefit from molecular targeted therapy. dc.contributor.author. Cirenajwis, Helena. en_US. ... Prediction of survival outcome and benefit from molecular targeted therapy." Oncotarget 6 (14): 12297-12309.. en. ... Prediction of survival outcome and benefit from molecular targeted therapy. en. ...
  https://dash.harvard.edu/handle/1/17820895?show=full
*  Republished: Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy...
Does smoking history matter in the era of molecular diagnostics and targeted therapy? ... Does smoking history matter in the era of molecular diagnostics and targeted therapy? ... molecular subgroups and identifying the difference according to smoking history may help optimise future targeted therapy. ... in adenocarcinoma of the lung we have switched to classifying non-small cell lung cancer into different individual molecular ...
  http://pmj.bmj.com/content/90/1062/228
*  Investigation of epidermal growth factor receptor and erbB-2 molecular targeted therapies in undifferentiated thyroid cancer...
Investigation of epidermal growth factor receptor and erbB-2 molecular targeted therapies in undifferentiated thyroid cancer ... Investigation of epidermal growth factor receptor and erbB-2 molecular targeted therapies in undifferentiated thyroid cancer ... Investigation of epidermal growth factor receptor and erbB-2 molecular targeted therapies in undifferentiated thyroid cancer ... Investigation of epidermal growth factor receptor and erbB-2 molecular targeted therapies in undifferentiated thyroid cancer ...
  http://cancerres.aacrjournals.org/content/64/7_Supplement/1046.3
*  KAKEN - Research Projects | Development of molecular target therapy against chimeric oncogene using siRNA (KAKENHI-PROJECT...
Development of molecular target therapy against chimeric oncogene using siRNA. Research Project ... Journal Article] The human papillomavirus E6 and E7 inducible oncogene, hWAPL,exhibits potential as a therapeutic target.2005. ... hWAPL, exhibits potential as a therapeutic target.2005. *. Author(s). Kuroda, M, et al. ... The discovery of RNA interference (RNAi) in eukaryotic cells is a major breakthrough in the recent progress of the molecular ...
  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15590318/
*  New Molecular Test Kit May Help Predict Response to Targeted Therapy in Clear Cell Renal Cell Carcinoma Patients | Medgadget
New Molecular Test Kit May Help Predict Response to Targeted Therapy in Clear Cell Renal Cell Carcinoma Patients. August 11th, ... to develop a practical molecular assay that can identify subtypes with differential prognosis and response to targeted therapy ... This method are used to study the molecular and biology including structural and functional of biomedicine, molecular ... for patients receiving targeted therapy, radiologic response.". European Urology: A Multigene Assay Identifying Distinct ...
  https://www.medgadget.com/2014/08/new-molecular-test-kit-may-help-predict-response-to-targeted-therapy-in-clear-cell-renal-cell-carcinoma-patients.html
*  Molecular Targeted Therapies - OzRadOnc
Molecular target therapies are agents which attempt to disrupt the molecular processes which allow the malignant cells to ... Methods which block or alter DNA repair can be used as targeted therapies.. In cells with BRCA1 mutations, homologous ... These proteins are often targeted by monoclonal antibodies targeted against their extracellular domain. These antibodies serve ... Drugs which effect apoptosis would therefore target:. *Mutated forms of death receptors which can be targeted with antibodies, ...
  http://ozradonc.wikidot.com/molecular-targeted-therapies
*  New molecular targeted therapies for advanced non-small-cell l...
New molecular targeted therapies for advanced non-small-cell lung cancer.: Non-small-cell lung cancer (NSCLC) is a uniformly ... New molecular targeted therapies for advanced non-small-cell lung cancer.. Authors * Méndez, Míriam1 ... Targeted Therapies License. Unknown Abstract. Non-small-cell lung cancer (NSCLC) is a uniformly fatal disease and most patients ... However, novel targeted therapies that interfere with other dysregulated pathways in lung cancer are already in the clinic. ...
  https://www.mysciencework.com/publication/show/new-molecular-targeted-therapies-advanced-non-small-cell-lung-cancer-811aeaaa
*  Targeted Therapies for Non-Small Cell Lung Cancer: An Evolving Landscape | Molecular Cancer Therapeutics
Targeted Therapies for Non-Small Cell Lung Cancer: An Evolving Landscape. Sumanta Kumar Pal, Robert A. Figlin and Karen Reckamp ... Targeted Therapies for Non-Small Cell Lung Cancer: An Evolving Landscape. Sumanta Kumar Pal, Robert A. Figlin and Karen Reckamp ... Targeted Therapies for Non-Small Cell Lung Cancer: An Evolving Landscape. Sumanta Kumar Pal, Robert A. Figlin and Karen Reckamp ... Targeted Therapies for Non-Small Cell Lung Cancer: An Evolving Landscape Message Subject (Your Name) has forwarded a page to ...
  http://mct.aacrjournals.org/content/early/2010/06/18/1535-7163.MCT-10-0239
*  Meeting Report on the Second Targeted Tumor Therapies | Molecular Cancer Therapeutics
Meeting Report on the Second Targeted Tumor Therapies Message Subject (Your Name) has forwarded a page to you from Molecular ... Meeting Report on the Second Targeted Tumor Therapies. Christopher Bachran and Hendrik Fuchs ... The fourth Fabisch Symposium was the second on Targeted Tumor Therapies and held from April 1-3, 2009 in Berlin, Germany. The ... Thank you for sharing this Molecular Cancer Therapeutics article.. NOTE: We request your email address only to inform the ...
  http://mct.aacrjournals.org/content/early/2010/01/02/1535-7163.MCT-09-0491